about
Environmental Risk Factors in Psoriasis: The Point of View of the NutritionistPsoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique backgroundPsoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications.Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet?Non-alcoholic fatty liver disease and psoriasis: So far, so near.Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture.Presence of selected metabolic syndrome components in patients with psoriasis vulgaris.Profile of patients admitted to a triage dermatology clinic at a tertiary hospital in São Paulo, Brazil.An evolution in switching therapy for psoriasis patients who fail to meet treatment goals.Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab.Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population.Prevalence of Metabolic Syndrome in Psoriasis and Levels of Interleukin-6 and Tumor Necrosis Factor-α in Psoriasis Patients with Metabolic Syndrome: Indian Tertiary Care Hospital StudyPsoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?Moderate to severe psoriasis treatment challenges through the era of biological drugs.The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis.Prevalence and Possible Role of Candida Species in Patients with Psoriasis: A Systematic Review and Meta-Analysis.Young patients with risk factors prevalent in the elderly – differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registers.
P2860
Q26741784-FF41E83F-985B-43FA-A926-7D2F256029C0Q26765175-2CB0DE02-E0EE-4E94-B194-F8365A4E764CQ35045850-0B4815AF-B0AC-485B-AA7A-2C977EDFF3B7Q35047630-14CE793E-9FCA-4476-AC48-47F9D62B14BEQ35237307-32D4C2E1-190D-4BF7-9D63-8A098AFBC19DQ36369917-781FA185-BA78-4099-9B26-0AE7FE760BCBQ36946167-E00AA758-851D-492B-828D-1FDB0AE4678AQ37078902-BF9C0523-B3A1-4FBB-89DE-D87CF0B3FAA1Q37295966-B49BE578-B5CB-4320-97DD-D8880658ABF7Q37712237-A3AB7427-970E-44A3-98A3-30E1F1C1698AQ38854206-D8ABC9A4-1D57-48C1-BB4D-2D1D74089A2DQ41515491-E86DF23F-DABC-41ED-8EDD-B572DE631443Q41693144-D92B14A7-14ED-4B4D-AC24-6D36E5842991Q46452013-DEE213ED-1C83-41CB-B127-F45F435FAAF9Q47644680-3D744C36-915B-4C72-99B4-E2A4841502EFQ55041240-6657F62A-6B20-462A-901C-999545A4AAB7Q55312824-1AB38080-1739-4551-B629-779145FE8ED7
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Psoriasis and comorbidities: links and risks.
@ast
Psoriasis and comorbidities: links and risks.
@en
Psoriasis and comorbidities: links and risks.
@nl
type
label
Psoriasis and comorbidities: links and risks.
@ast
Psoriasis and comorbidities: links and risks.
@en
Psoriasis and comorbidities: links and risks.
@nl
prefLabel
Psoriasis and comorbidities: links and risks.
@ast
Psoriasis and comorbidities: links and risks.
@en
Psoriasis and comorbidities: links and risks.
@nl
P2860
P356
P1476
Psoriasis and comorbidities: links and risks.
@en
P2093
Catherine Ni
Melvin W Chiu
P2860
P304
P356
10.2147/CCID.S44843
P407
P577
2014-04-17T00:00:00Z